StageZero Life Sciences Ltd.
SZLS
Rangering i aksjer
#36000
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise... StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples. Its flagship product, Aristotle, exemplifies this innovation; it's a comprehensive multi-cancer panel that simultaneously screens for numerous cancers from a single blood draw, boasting impressive sensitivity and specificity for each identified malignancy. Beyond Aristotle, the company's portfolio includes ColonSentry, a blood-based test gauging colorectal cancer risk; COVID-19 PCR testing and general blood analysis services; the Prostate Health Index for prostate cancer screening; and BreastSentry, designed to evaluate a woman's susceptibility to breast cancer. Established in 1998, StageZero Life Sciences Ltd. maintains its headquarters in Richmond Hill, Canada.
Aksjekurs
$0.02770208
Sist synkronisert: 2025-03-10
Markedsverdi
$2.92M
Endring (1 dag)
-0.46%
Endring (1 år)
443.18%
Land
CA
Handel StageZero Life Sciences Ltd. (SZLS)
Kategori
Healthcare
Aksjeprishistorikk for StageZero Life Sciences Ltd. (SZLS)
Høyeste sluttskurs: $0.00 den 2026-10-01
Laveste sluttskurs: $2.81 den 2009-09-01
Laveste sluttskurs: $2.81 den 2009-09-01
Aksjeprishistorikk for StageZero Life Sciences Ltd. fra 2009 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -73.56% |
| 2024 | -62.97% |
| 2023 | -33.87% |
| 2022 | -78.51% |
| 2021 | -55.53% |
| 2020 | 1,478.24% |
| 2019 | 52.97% |
| 2018 | -82.67% |
| 2017 | -60.46% |
| 2016 | 1,319.73% |
| 2015 | -98.57% |
| 2014 | 178.20% |
| 2013 | -10.96% |
| 2012 | -45.98% |
| 2011 | -18.68% |
| 2010 | -42.93% |
| 2009 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
